TJHA
FBIO icon

Thomas J. Herzfeld Advisors’s Fortress Biotech FBIO Stock Holding History

Thomas J. Herzfeld Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-172
Closed -$2K – 297
2018
Q4 		$2K Sell
172
-11
-6% -$184 ﹤0.01% 292
2018
Q3 		$4K Hold
183
– – ﹤0.01% 275
2018
Q2 		$8K Buy
+183
New +$10.3K ﹤0.01% 255

Other funds holding FBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $25.2B AUM 30.31% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HAG
HighPoint Advisor Group Downers Grove, Illinois $2.39B AUM 28.86% 1-Year Est. Return

Thomas J. Herzfeld Advisors's FBIO Position: Q1 2019 in Review

Thomas J. Herzfeld Advisors sold out of Fortress Biotech (FBIO) in Q1 2019, closing a stake of 172 shares — an estimated $2K sold.

Thomas J. Herzfeld Advisors first reported a position in FBIO in Q2 2018 and held it in 3 quarters. The position peaked at $8K in Q2 2018. 49 funds tracked by Wall St. Rank hold FBIO as of Q1 2019.

  • Thomas J. Herzfeld Advisors reported no remaining Fortress Biotech position as of Q1 2019 after selling out during the quarter.
  • Thomas J. Herzfeld Advisors sold 172 Fortress Biotech shares in Q1 2019, an estimated $2K.
  • Thomas J. Herzfeld Advisors first reported a position in Fortress Biotech in Q2 2018 and held it in 3 quarters.
  • Thomas J. Herzfeld Advisors's Fortress Biotech position peaked at $8K in Q2 2018.
  • 49 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2019.

Based on Thomas J. Herzfeld Advisors's 13F filing for Q1 2019, filed 14 May 2019.